These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20558186)

  • 1. Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists.
    Alushin GM; Jane D; Mayer ML
    Neuropharmacology; 2011 Jan; 60(1):126-34. PubMed ID: 20558186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from crystal structures of kainate receptors.
    Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Neuropharmacology; 2017 Jan; 112(Pt A):16-28. PubMed ID: 27236079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding site and interlobe interactions of the ionotropic glutamate receptor GluK3 ligand binding domain revealed by high resolution crystal structure in complex with (S)-glutamate.
    Venskutonytė R; Frydenvang K; Gajhede M; Bunch L; Pickering DS; Kastrup JS
    J Struct Biol; 2011 Dec; 176(3):307-14. PubMed ID: 21907808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and pharmacological characterization of phenylalanine-based AMPA receptor antagonists at kainate receptors.
    Venskutonytė R; Frydenvang K; Valadés EA; Szymańska E; Johansen TN; Kastrup JS; Pickering DS
    ChemMedChem; 2012 Oct; 7(10):1793-8. PubMed ID: 22407805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1.
    Demmer CS; Møller C; Brown PM; Han L; Pickering DS; Nielsen B; Bowie D; Frydenvang K; Kastrup JS; Bunch L
    ACS Chem Neurosci; 2015 Jun; 6(6):845-54. PubMed ID: 25856736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
    Mayer ML; Ghosal A; Dolman NP; Jane DE
    J Neurosci; 2006 Mar; 26(11):2852-61. PubMed ID: 16540562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the GluK1 ligand-binding domain with kainate and the full-spanning positive allosteric modulator BPAM538.
    Bay Y; Cabello FJM; Koens CC; Frantsen SM; Pickering DS; Frydenvang K; Francotte P; Pirotte B; Kristensen AS; Bowie D; Kastrup JS
    J Struct Biol; 2024 Sep; 216(3):108113. PubMed ID: 39079583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Møllerud S; Hansen RB; Pallesen J; Temperini P; Pasini D; Bornholt J; Nielsen B; Mamedova E; Chalupnik P; Paternain AV; Lerma J; Diaz-delCastillo M; Andreasen JT; Frydenvang K; Kastrup JS; Johansen TN; Pickering DS
    ACS Chem Neurosci; 2019 Nov; 10(11):4685-4695. PubMed ID: 31622082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.
    Pallesen J; Møllerud S; Frydenvang K; Pickering DS; Bornholdt J; Nielsen B; Pasini D; Han L; Marconi L; Kastrup JS; Johansen TN
    ACS Chem Neurosci; 2019 Mar; 10(3):1841-1853. PubMed ID: 30620174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal chemistry of competitive kainate receptor antagonists.
    Larsen AM; Bunch L
    ACS Chem Neurosci; 2011 Feb; 2(2):60-74. PubMed ID: 22778857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and in vitro pharmacology of GluK1 and GluK3 antagonists. Studies towards the design of subtype-selective antagonists through 2-carboxyethyl-phenylalanines with substituents interacting with non-conserved residues in the GluK binding sites.
    Sköld N; Nielsen B; Olsen J; Han L; Olsen L; Madsen U; Kristensen JL; Pickering DS; Johansen TN
    Bioorg Med Chem; 2014 Oct; 22(19):5368-77. PubMed ID: 25172149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationships of novel phenylalanine-based amino acids as kainate receptors ligands.
    Szymańska E; Chałupnik P; Szczepańska K; Cuñado Moral AM; Pickering DS; Nielsen B; Johansen TN; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5568-5572. PubMed ID: 27765511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of a Series of l-trans-4-Substituted Prolines as Selective Antagonists for the Ionotropic Glutamate Receptors Including Functional and X-ray Crystallographic Studies of New Subtype Selective Kainic Acid Receptor Subtype 1 (GluK1) Antagonist (2S,4R)-4-(2-Carboxyphenoxy)pyrrolidine-2-carboxylic Acid.
    Krogsgaard-Larsen N; Delgar CG; Koch K; Brown PM; Møller C; Han L; Huynh TH; Hansen SW; Nielsen B; Bowie D; Pickering DS; Kastrup JS; Frydenvang K; Bunch L
    J Med Chem; 2017 Jan; 60(1):441-457. PubMed ID: 28005385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
    Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
    ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
    Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
    J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Functional Properties of Drosophila CNS Glutamate Receptors.
    Li Y; Dharkar P; Han TH; Serpe M; Lee CH; Mayer ML
    Neuron; 2016 Dec; 92(5):1036-1048. PubMed ID: 27889096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.
    Fisher JL
    Neuropharmacology; 2014 Oct; 85():9-17. PubMed ID: 24859608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective kainate receptor (GluK1) ligands structurally based upon 1H-cyclopentapyrimidin-2,4(1H,3H)-dione: synthesis, molecular modeling, and pharmacological and biostructural characterization.
    Venskutonyte R; Butini S; Coccone SS; Gemma S; Brindisi M; Kumar V; Guarino E; Maramai S; Valenti S; Amir A; Valadés EA; Frydenvang K; Kastrup JS; Novellino E; Campiani G; Pickering DS
    J Med Chem; 2011 Jul; 54(13):4793-805. PubMed ID: 21619066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.
    Assaf Z; Larsen AP; Venskutonytė R; Han L; Abrahamsen B; Nielsen B; Gajhede M; Kastrup JS; Jensen AA; Pickering DS; Frydenvang K; Gefflaut T; Bunch L
    J Med Chem; 2013 Feb; 56(4):1614-28. PubMed ID: 23414088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.